In a jaw-dropping move that has the baseball world buzzing, the New York Mets have reportedly agreed to a three-year, $126 million deal with star infielder Bo Bichette, according to league sources. But here's where it gets controversial: this blockbuster signing comes just 12 hours after the Mets missed out on Kyle Tucker, a player they had been openly pursuing. So, why the sudden shift? And what does this mean for the Mets' lineup? Let’s break it down.
Bichette’s deal, which includes opt-out clauses after the first two seasons and no deferrals, is pending a physical. And this is the part most people miss: while Bichette is a two-time All-Star shortstop, the Mets plan to shift him to third base, according to a league source. This move could push Brett Baty, who has primarily played third base, into a more prominent role in left field. It’s a bold strategy—but will it pay off?
What’s even more surprising is that the Mets weren’t publicly linked to Bichette until recently. Their interest in Tucker was no secret, but Bichette only emerged as a serious contender earlier this month, when the Mets began meeting with him. Meanwhile, the Philadelphia Phillies were also in the running, reportedly leaving a videoconference with Bichette feeling optimistic. To land him, the Phillies would have had to overhaul their core, potentially letting go of J.T. Realmuto and trading Alec Bohm. Instead, Bichette will now be a division rival—a tough pill for Phillies fans to swallow.
At 27, Bichette is one of baseball’s premier contact hitters, ranked No. 2 on The Athletic’s Top 50 Big Board. A Florida native, he’s a firm believer in the importance of batting average, and his stats back him up: he’s hit over .290 in six of his first seven MLB seasons with the Toronto Blue Jays, leading the American League in hits twice. Even in 2025, despite missing the final month of the regular season, he remained among the league leaders in hits. While his fielding has never been his strongest suit, his offensive prowess earned him multiple All-Star nods and MVP votes.
Here’s where it gets emotional: Bichette’s journey hasn’t been without setbacks. In early September, he suffered a right knee sprain sliding into home plate at Yankee Stadium, sidelining him for the Jays’ first two playoff rounds. He returned for the World Series, playing through pain at second base, and delivered a three-run homer in Game 7 that seemed like a career-defining moment—until the Los Angeles Dodgers rallied to win the championship. It was a heartbreaking end, but Bichette’s resilience shone through.
After a disappointing 2024 season marred by injuries and a career-low .225 average, Bichette bounced back in 2025, hitting .311 with 3.5 WAR and proving himself on the biggest stage. This resurgence made him one of the most sought-after free agents, though his free agency extended into 2026. Now, with the Mets, he has a chance to rewrite his legacy.
But here’s the question that’s dividing fans: Is Bichette worth the $126 million price tag? And can he thrive at third base, a position he’s not accustomed to? The Mets are betting big on his bat, but only time will tell if this move pays dividends. What do you think? Is this a game-changer for the Mets, or a risky gamble? Let us know in the comments!
